Our results contribute to these findings by demonstrating that hypoxic conditions trigger a HIF-1α-mediated upregulation of TNS4, proposing it as a potential therapeutic target for HNSCC. The gene discussed is TNS4; the disease is head and neck squamous cell carcinoma.